Fresenius Kabi Philippines – Our Local History

Long before Fresenius Kabi Philippines, Inc. was registered as a corporation in September 2004, products made by Fresenius Kabi had already been in the Philippine market serving the needs of chronically and critically ill patients through licensed distributors. 

This dedication continued when Fresenius Kabi Philippines, Inc. first started commercial operations as a corporation in January 2005.  Being a wholly-owned subsidiary of Fresenius Kabi Deutschland GmbH, a division of Fresenius SE & Co. KGaA in Germany, we are proud to carry the values, mission and vision of a global healthcare company.

In 2008, we acquired Dabur Pharma Ltd., a move which introduced us in the field of oncology generics.  Five years later, we also acquired the transfusion technology products of Fenwal.  Since then, our Company has only continued to grow and established itself as a formidable player in the pharmaceutical industry.  Our products now consist of keto amino acids, IV drugs, parenteral nutrition, enteral nutrition, infusion and transfusion medical devices, volume therapy, standard solutions and oncology.

Even up to now, our commitment to delivering quality products to our customers has not wavered and we are continuously seeking out ways to improve our service with the support of our business partners throughout the value chain.  We promise to stay true to our philosophy of “Caring for Life”.